bromocriptine has been researched along with physostigmine in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (39.13) | 18.7374 |
1990's | 6 (26.09) | 18.2507 |
2000's | 5 (21.74) | 29.6817 |
2010's | 2 (8.70) | 24.3611 |
2020's | 1 (4.35) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Avanzini, G; Caraceni, T; Giovannini, P; Girotti, F | 1 |
Battista, AF; Goldstein, M; Miyamoto, T | 1 |
Carolei, A; Margotta, V; Palladini, G | 1 |
Inano, S; Kaneyuki, H; Mizuki, Y; Ukita, T; Ushijima, I; Yamada, M | 1 |
Jamshidzadeh, A; Zarrindast, MR | 1 |
Poddar, MK; Ray, SK | 1 |
Chee, KY; Sachdev, P | 1 |
Poursoltan, M; Zarrindast, MR | 1 |
Hara, T; Kaneyuki, H; Kishimoto, O; Mizuki, Y; Soeda, K; Tsutsumi, C; Ushijima, I; Yamada, M | 1 |
Mizuki, Y; Ushijima, I; Yamada, M | 1 |
Berger, PA; Stahl, SM | 1 |
Fincke, M; Gothóni, P; Lehtinen, M | 1 |
Ghosh, MN; Gopalakrishnan, V; Pillai, NP; Ramaswamy, S | 1 |
Ghazi-Khansari, M; Heidari, I; Zarrindast, MR | 1 |
Bani-Assadi, S; Ghazi-Khansari, M; Rezvani, N; Zarrindast, MR | 1 |
Kurasawa, M; Nakamura, K | 1 |
de Boissezon, X; de Boysson, C; Démonet, JF; Peran, P | 1 |
Brown, J; Chan, BS; Downes, MA; Harris, K; Isoardi, KZ; Seebaluck, J | 1 |
2 review(s) available for bromocriptine and physostigmine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacotherapy of aphasia: myth or reality?
Topics: Amphetamine; Aphasia; Bromocriptine; Cholinesterase Inhibitors; Clinical Trials as Topic; Donepezil; Dopamine Agents; Fluoxetine; GABA Agonists; Humans; Indans; Neuroprotective Agents; Paroxetine; Physostigmine; Piperidines; Piracetam; Pyridines; Selective Serotonin Reuptake Inhibitors; Serotonin; Stroke; Zolpidem | 2007 |
2 trial(s) available for bromocriptine and physostigmine
Article | Year |
---|---|
Pharmacological characterization of tardive akathisia.
Topics: Administration, Oral; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Arousal; Atenolol; Benztropine; Brain; Bromocriptine; Chronic Disease; Clonidine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Dyskinesia, Drug-Induced; Humans; Infusions, Intravenous; Male; Metoclopramide; Metoprolol; Physostigmine; Propranolol; Psychomotor Agitation; Schizophrenia, Paranoid | 1990 |
Bromocriptine, physostigmine, and neurotransmitter mechanisms in the dystonias.
Topics: Adult; Bromocriptine; Child; Clinical Trials as Topic; Dose-Response Relationship, Drug; Dystonia; Female; Haloperidol; Humans; Male; Middle Aged; Neurotransmitter Agents; Physostigmine; Receptors, Cholinergic; Receptors, Dopamine; Torticollis | 1982 |
19 other study(ies) available for bromocriptine and physostigmine
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Pharmacology of Huntington's chorea. Personal experience.
Topics: Acetates; Adult; Aminobutyrates; Blood Cell Count; Bromocriptine; Female; gamma-Aminobutyric Acid; Haloperidol; Humans; Huntington Disease; Kidney Function Tests; Liver Function Tests; Male; Middle Aged; Physostigmine; Receptors, Dopamine; Valerates; Valproic Acid | 1977 |
Modification of involuntary movements by centrally acting drugs.
Topics: Aminooxyacetic Acid; Animals; Atropine; Bicuculline; Bromocriptine; Dopamine; Haloperidol; Haplorhini; Levodopa; Movement Disorders; Physostigmine; Picrotoxin; Piperazines; Piribedil; Receptors, Drug; Synaptic Transmission; Thalamic Nuclei; Theophylline | 1975 |
Proposal of a new model with dopaminergic-cholinergic interactions for neuropharmacological investigations.
Topics: Acetylcholine; Animals; Apomorphine; Atropine; Benserazide; Bromocriptine; Central Nervous System; Dextroamphetamine; Dopamine; Extrapyramidal Tracts; Haloperidol; Levodopa; Models, Neurological; Motor Activity; Physostigmine; Piribedil; Planarians; Reserpine; Synaptic Transmission; Turbellaria | 1975 |
Behavioral effects of dilazep on cholinergic, dopaminergic, and purinergic systems in the rat.
Topics: Animals; Behavior, Animal; Bromocriptine; Dilazep; Dopamine; Dopamine Agents; Injections, Intraperitoneal; Male; Parasympathetic Nervous System; Parasympathomimetics; Physostigmine; Pilocarpine; Purines; Rats; Rats, Wistar; Yawning | 1992 |
Inhibitory effect of morphine on yawning induced by cholinoceptor and dopamine D2 receptor activation in rats.
Topics: Animals; Bromocriptine; Depression, Chemical; Dose-Response Relationship, Drug; Male; Morphine; Naloxone; Physostigmine; Pilocarpine; Rats; Receptors, Cholinergic; Receptors, Dopamine; Receptors, Dopamine D2; Yawning | 1992 |
Interaction of central serotonin and dopamine in the regulation of carbaryl-induced tremor.
Topics: 5-Hydroxytryptophan; Acetylcholinesterase; Animals; Atropine; Behavior, Animal; Brain Chemistry; Bromocriptine; Carbaryl; Corpus Striatum; Dopamine; Haloperidol; Hydroxyindoleacetic Acid; Male; Methysergide; Physostigmine; Rats; Serotonin; Tremor | 1990 |
Interactions of drugs acting on central dopamine receptors and cholinoceptors on yawning responses in the rat induced by apomorphine, bromocriptine or physostigmine.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Atropine; Behavior, Animal; Benzazepines; Bromocriptine; Drug Interactions; Male; Physostigmine; Rats; Receptors, Cholinergic; Receptors, Dopamine; Theophylline; Yawning | 1989 |
[Effects of bifemelane on central dopaminergic and cholinergic systems in rats].
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antidepressive Agents; Apomorphine; Benzazepines; Benzhydryl Compounds; Bromocriptine; Dopamine Agents; Drug Interactions; Male; Physostigmine; Pilocarpine; Rats; Rats, Inbred Strains; Stereotyped Behavior; Yawning | 1988 |
Multifocal sites of action involved in dopaminergic-cholinergic neuronal interactions in yawning.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; alpha-Methyltyrosine; Animals; Apomorphine; Benzazepines; Bromocriptine; Male; Methyltyrosines; Physostigmine; Pilocarpine; Rats; Rats, Inbred Strains; Receptors, Cholinergic; Receptors, Dopamine; Yawning | 1988 |
Drugs for Parkinson's disease reduce tremor induced by physostigmine.
Topics: Amantadine; Animals; Antiparkinson Agents; Atropine; Biperiden; Bromocriptine; Male; Physostigmine; Pimozide; Rats; Rats, Inbred Strains; Tremor | 1983 |
Effect of prolactin and bromocriptine on intestinal transit in mice.
Topics: Animals; Bromocriptine; Drug Interactions; Female; Gastric Emptying; Gastrointestinal Motility; Male; Mice; Morphine; Physostigmine; Prolactin | 1981 |
Effects of lead exposure on bromocriptine-induced penile erection in rats.
Topics: Animals; Bromocriptine; Dopamine Agonists; Dose-Response Relationship, Drug; Fresh Water; Injections, Intraperitoneal; Lead; Male; Organometallic Compounds; Parasympathomimetics; Penile Erection; Physostigmine; Rats; Rats, Wistar; Spectrophotometry, Atomic | 1997 |
Effects of lead exposure on licking and yawning behaviour in rats.
Topics: Animals; Apomorphine; Behavior, Animal; Bromocriptine; Cholinesterase Inhibitors; Dopamine Agonists; Dose-Response Relationship, Drug; Lead Poisoning; Male; Organometallic Compounds; Physostigmine; Poisons; Rats; Rats, Wistar; Yawning | 1998 |
Anxiolytic effects of aniracetam in three different mouse models of anxiety and the underlying mechanism.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Bromocriptine; Diazepam; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Fear; Fluvoxamine; Haloperidol; Indophenol; Male; Maze Learning; Mecamylamine; Mice; Mice, Inbred ICR; Moclobemide; Motor Activity; Nicotine; Nicotinic Antagonists; Nortriptyline; Physostigmine; Picolinic Acids; Pyrrolidinones; Serotonin Antagonists; Serotonin Receptor Agonists; Social Behavior; Stress, Psychological | 2001 |
Case series profile of olanzapine post-injection delirium/sedation syndrome.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bromocriptine; Delirium; Female; Humans; Male; Middle Aged; Olanzapine; Physostigmine; Rivastigmine | 2023 |